Diastolic strain time as predictor for systolic dysfunction among patients with active breast cancer.

Echocardiography
Aviram HochstadtMichal Laufer-Perl

Abstract

Although diastolic dysfunction is common among patients treated with cancer therapy, no clear evidence has been shown that it predicts systolic dysfunction. This study evaluated the correlation of diastolic strain time (Dst) with the routine echocardiography diastolic parameters and estimated its role in the early detection of cardiotoxicity among patients with active breast cancer. Data were collected as part of the Israel Cardio-Oncology Registry (ICOR), a prospective registry enrolling all adult patients referred to the cardio-oncology clinic. All patients with breast cancer, planned for Doxorubicin therapy, were included. Echocardiography, including global longitudinal systolic strain (GLS) and Dst, was assessed at baseline before chemotherapy (T1), during Doxorubicin therapy (T2) and after the completion of Doxorubicin therapy (T3). Cardiotoxicity was determined by GLS relative reduction of ≥15%. Dst was assessed as the time measured (ms) of the myocardium lengthening during diastole. Among 69 patients, 67 (97.1%) were females with a mean age of 52 ± 13 years. Dst was significantly associated with the routine diastolic parameters. Significant GLS reduction was observed in 10 (20%) patients at T3. Both in a univariate and a...Continue Reading

References

Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer
Feb 7, 2006·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Roberto M LangUNKNOWN European Association of Echocardiography, European Society of Cardiology
Feb 19, 2008·Journal of the American College of Cardiology·Steven J LesterJames B Seward
Dec 2, 2008·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Ruxandra JurcutJens-Uwe Voigt
Oct 16, 2009·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Swee Guan TeoTiong Cheng Yeo
Apr 7, 2010·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Holly GeyerPartho P Sengupta
Jan 20, 2012·Journal of cardiovascular ultrasound·Jae-Hyeong Park, Thomas H Marwick
Aug 31, 2014·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Juan Carlos PlanaPatrizio Lancellotti
Aug 25, 2015·Journal of Oncology·Fausto PizzinoBijoy K Khandheria
Apr 3, 2016·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Sherif F NaguehAlan D Waggoner
Jan 9, 2017·European Heart Journal Cardiovascular Imaging·Clément CharbonnelBernard Livarek
Apr 6, 2017·European Heart Journal Cardiovascular Imaging·Ciro SantoroMaurizio Galderisi
Apr 12, 2017·Antioxidants & Redox Signaling·Carlo Gabriele TocchettiGiuseppe Mercuro
Oct 13, 2018·Journal of Cardiovascular Imaging·Ju-Hee Lee, Jae-Hyeong Park
Oct 28, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Kisho OhtaniHiroyuki Tsutsui
Jun 20, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Michal Laufer-PerlZach Rozenbaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.